Back to Companies
Denali Therapeutics Inc.
DNLINasdaqCIK: 0001714899
Recent Form 4 activity at Denali Therapeutics Inc. (DNLI) spans 27 filings across 12 insiders (all of them on the sell side). Purchases total $0 against $8.8M in sales — heavily weighted toward selling, for net sales of $8.8M. Watts Ryan J. (President and CEO, Director) is the most active by dollar volume, and the single largest transaction was $8.5M by Watts Ryan J.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$20.5M
Purchases
$0
Sales
$8.8M
Unique Insiders
12
Recent Insider Trades
27 loaded
| Sep 9 | DNLI Denali Therapeutics Inc. | Chin Peter Scott | Chief Medical Officer | Sell | $36.9K |
| Sep 4 | DNLI Denali Therapeutics Inc. | Thornberry Nancy | Director | Sell | $261.9K |
| Sep 3 | DNLI Denali Therapeutics Inc. | Schuth Alexander O. | COFO and Secretary | Sell | $64.9K |
| Aug 14 | DNLI Denali Therapeutics Inc. | Watts Ryan J. | President and CEO, Director | Gift | $0 |
| Aug 13 | DNLI Denali Therapeutics Inc. | Schuth Alexander O. | COFO and Secretary | Sell | $71.6K |
| Jun 5 | DNLI Denali Therapeutics Inc. | Cook Jennifer E. | Director | Grant | $378.0K |
| Jun 5 | DNLI Denali Therapeutics Inc. | BAKER BROS. ADVISORS LP | Insider | Grant | $756.0K |
| Jun 5 | DNLI Denali Therapeutics Inc. | Van Hauwermeiren Timothy | Director | Grant | $378.0K |
| Jun 5 | DNLI Denali Therapeutics Inc. | Thornberry Nancy | Director | Grant | $378.0K |
| Jun 5 | DNLI Denali Therapeutics Inc. | Krognes Steve E. | Director | Grant | $378.0K |
| Jun 5 | DNLI Denali Therapeutics Inc. | FLATLEY JAY T | Director | Grant | $378.0K |
| Jun 5 | DNLI Denali Therapeutics Inc. | Klein Peter S | Director | Grant | $378.0K |
| Jun 5 | DNLI Denali Therapeutics Inc. | Schenkein David P | Director | Grant | $378.0K |
| Apr 20 | DNLI Denali Therapeutics Inc. | Chin Peter Scott | Chief Medical Officer | Other | $0 |
| Apr 21 | DNLI Denali Therapeutics Inc. | Chin Peter Scott | Chief Medical Officer | Other | $0 |
| Jan 8 | DNLI Denali Therapeutics Inc. | Watts Ryan J. | President and CEO, Director | Sell | $580.8K |
| Jan 8 | DNLI Denali Therapeutics Inc. | Schuth Alexander O. | COFO and Secretary | Sell | $284.1K |
| Jan 5 | DNLI Denali Therapeutics Inc. | Watts Ryan J. | President and CEO, Director | Grant | $3.9M |
| Jan 5 | DNLI Denali Therapeutics Inc. | Schuth Alexander O. | COFO and Secretary | Grant | $2.8M |
| Dec 15 | DNLI Denali Therapeutics Inc. | BAKER BROS. ADVISORS LP | Insider | Other | $22.9K |
| Nov 6 | DNLI Denali Therapeutics Inc. | Van Hauwermeiren Timothy | Director | Other | $0 |
| Nov 6 | DNLI Denali Therapeutics Inc. | Van Hauwermeiren Timothy | Director | Grant | $475.9K |
| Sep 5 | DNLI Denali Therapeutics Inc. | Watts Ryan J. | President and CEO, Director | Gift | $0 |
| Aug 14 | DNLI Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | $51.7K |
| Aug 14 | DNLI Denali Therapeutics Inc. | Schuth Alexander O. | COFO and Secretary | Sell | $39.9K |
| Aug 7 | DNLI Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Exercise | $60.7K |
| Jul 11 | DNLI Denali Therapeutics Inc. | Watts Ryan J. | President and CEO, Director | Sell | $7.4M |
27 filings